Filter
1503
Text search:
CDC
United
States
Featured
161
425
Language
Document type
809
229
212
94
73
37
27
10
7
4
1
Countries / Regions
69
46
44
40
38
38
38
32
31
27
23
21
21
20
20
20
19
19
19
18
17
16
16
16
15
14
14
13
13
12
10
9
8
8
8
8
7
7
7
7
7
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
541
142
92
76
58
26
22
Toolboxes
169
116
113
83
82
53
51
45
44
40
38
33
24
19
18
15
14
13
13
13
12
12
12
7
Accessed at March 2014
Cette liste de contrôle devrait aider les pays à évaluer et à tester leur niveau de préparation pour faire face à la propagation de maladie à virus Ebola. Elle doit également servir d'outil pour identifier des actions concrètes à prendre et les moyens pour la communauté internationale de
...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
Progress Report
This algorithm is addressed to laboratories
with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp
...
Methodological field approaches for scientists with a basic background in entomology to prepare and implement a yellow fever entomological assessment during outbreaks
Bulletin of the World Health Organization; http://dx.doi.org/10.2471/BLT.16.176677
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
BMC Medicine201614:112 DOI: 10.1186/s12916-016-0660-0
